Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (81-90 of 318) with videos related to

Pageof 32
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|September 8, 2022
Liver biopsy is associated with increased body weight loss in patients with non-alcoholic steatohepatitisGianluca Franchellucci, Maria Terrin, Alessio Aghemo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 16, 2021
Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipientsPierluigi Toniutto, Alessio Aghemo, Paolo Grossi, et al.
Clinical and Molecular Hepatology|May 3, 2019
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failureTommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Hepatology (Baltimore, Md.)|June 30, 2012
Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice?Enrico Galmozzi, Stella De Nicola, Alessio Aghemo, et al.
Journal of Hepatology|January 31, 2012
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipientsMaria Francesca Donato, Enrico Galmozzi, Cristina Rigamonti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
COVID-19 and the liver: A 2021 updateCatherine W Spearman, Alessio Aghemo, Luca Valenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 13, 2016
Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Emanuela Orsi, Valeria Grancini, Stefano Menini, et al.
Hepatology (Baltimore, Md.)|September 3, 2010
Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapyAlessio Aghemo, Maria Grazia Rumi, Stella De Nicola, et al.
Hepatology (Baltimore, Md.)|January 30, 2009
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?Alessio Aghemo, Maria Grazia Rumi, Gian Maria Prati, et al.
Seminars in Liver Disease|February 29, 2020
Postsustained Virological Response Management in Hepatitis C PatientsChiara Masetti, Ana Lleo, Matteo Colombo, et al.
Pageof 32

Showing results (81-90 of 318) with videos related to

Sort By:
Pageof 32
Liver International : Official Journal of the International Association for the Study of the Liver|September 8, 2022
Liver biopsy is associated with increased body weight loss in patients with non-alcoholic steatohepatitisGianluca Franchellucci, Maria Terrin, Alessio Aghemo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 16, 2021
Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipientsPierluigi Toniutto, Alessio Aghemo, Paolo Grossi, et al.
Clinical and Molecular Hepatology|May 3, 2019
Upcoming direct acting antivirals for hepatitis C patients with a prior treatment failureTommaso Lorenzo Parigi, Maria Corina Plaz Torres, Alessio Aghemo
Hepatology (Baltimore, Md.)|June 30, 2012
Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice?Enrico Galmozzi, Stella De Nicola, Alessio Aghemo, et al.
Journal of Hepatology|January 31, 2012
Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipientsMaria Francesca Donato, Enrico Galmozzi, Cristina Rigamonti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
COVID-19 and the liver: A 2021 updateCatherine W Spearman, Alessio Aghemo, Luca Valenti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 13, 2016
Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Emanuela Orsi, Valeria Grancini, Stefano Menini, et al.
Hepatology (Baltimore, Md.)|September 3, 2010
Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapyAlessio Aghemo, Maria Grazia Rumi, Stella De Nicola, et al.
Hepatology (Baltimore, Md.)|January 30, 2009
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?Alessio Aghemo, Maria Grazia Rumi, Gian Maria Prati, et al.
Seminars in Liver Disease|February 29, 2020
Postsustained Virological Response Management in Hepatitis C PatientsChiara Masetti, Ana Lleo, Matteo Colombo, et al.
Pageof 32